Dopamine creates a physical barrier to inhibit prolactin release in mammotrophs of estradiol-primed male rats.

After finding that ergocristine and somatostatin can cause extensive changes in mammotroph ultrastructure within 2 min of administration, we chose dopamine, the putative physiological prolactin-inhibiting factor, to correlate ultrastructural changes to inhibition of prolactin release. In order to choose a dose of dopamine for this study we tested the effects of 2 doses of dopamine (10 and 1,000 micrograms/kg) on inhibition of prolactin release. The higher dose of dopamine (1,000 micrograms/kg) completely inhibited prolactin release immediately (in less than 2 min) and maintained complete blockage for a period of 14 min. For the ultrastructural study we injected dopamine (1,000 micrograms/kg) in the right atrium of conscious free-moving rats through indwelling cannulae, and killed the rats by decapitation 2 min after dopamine administration. The following changes in mammotrophs were observed after the dopamine treatment: (1) increased numbers of secretory granules, (2) peripheral relocation of rough endoplasmic reticulum, and (3) increased numbers of 'intracellular bodies' (putative prolactin granule disposal system) associated with secretory granules. Because these rapid ultrastructural changes have been observed after treatment with three different compounds (dopamine, somatostatin and ergocristine), we do not believe that they are the unique effect of any one compound but the common denominator of the three compounds, i.e., inhibition of prolactin secretion being closely linked to the ultrastructural changes. We thus propose that the extensive ultrastructural changes that occurred in such a short period of time following dopamine administration are the mechanism of inhibition of prolactin release.